OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

Solent Multiple Sclerosis Therapies Limited

Financial Accounts for the Period Ended

31 March 2021

Company Registration Number: 2215154

Solent Multiple Sclerosis Therapies Limited Report and Accounts for the Period Ended 31 March 2021

CONTENTS PAGES
Report ofthe Directors 1
Report ofthe Accountant 2
Statement of Financial Activities 3
Income and Expenditure Account 4
Balance Sheet 5-6
Notes to the Accounts 7-10
The following pages do notform part ofthe statutory accounts.
Summary Income and ExpenditureAccount 11
Income Deiail 12
Physio/Osteo/Reflex/Shiatsu analysis 13
Bank Balances 14
Fixed Assets 15
DetailedIncomeandExpenditureAccount 16

Solent Multiple Sclerosis Therapies Limited Accounts for the Period Ended 31 March 2021

Trustees G Woodhouse - Acting Chairman L Balsom - Company Secretary (Resigned 30.07.2021) D Revill -Company Secretary (Appointed 15.10.2021) P Lee S Stroud A Alexander S Emery A Sandford E Woodhouse R Moorhead D Revill (Appointed 07.04.2021) Registered Office Bradbury House 56 Hewett Road North End Portsmouth Hampshire PO2 0QP Bankers Lloyds TSB plc ; 80NorthLondonEnd Road Portsmouth Hampshire PO2 OLX CAF Bank Limited 25 Kings Hill Avenue Kings Hill West Mailing Kent ME19 4JG Company Number 2215154 Accountants Hunter Simmons Ltd EMP Building, Unit 1 4 Solent Road Havant Hampshire POS 1JH

,

.

Solent Multiple Sclerosis Therapies Limited Report of the Directors for the Period Ended 31 March 2021

Report of the Directars

The diractors herewith present the accounts for the period ended 31 March 2021.

Activities of the Company

The company's principal activity is to aid the condition of those suffering from multiple sclerosis by providing guidance, practical support and therapy to those such persons.

Directors

The directors of the company throughout the year were as follows: P Lee A Alexander S Emery A Sandford E Woodhouse R Moorhen S Stroud G Woodhouse D Revill . The directorsi hold any shares in the company. Charitable Status The company is @ registered charity with the Charity Commissioners in England and Wales.

.

Company Number and Charity Number

The company registered number is 2215154 and the Registered Charity number is 299545. Governing Document

The governing document is the Memorandum and Articles of Association.

Trustees

The directors have produced a Directors’ Report as required by Company Law instead of a Trustees' Report.

Registered Office

The registered office of the charity is Bradbury House, 56 Hewett Road, North End, Portsmouth, Hampshire PO2 DOP,

.

Exemptions

Advantage has heen taken In the préparation of the Directors' Report of the special exemptions applicable to smali companies conferred by Part 15 of the Companies Act 2006.

By Order of the Board ve ct iss.sL Revill - Company Secretary nates |SLIE/ 20 |

|

|

Accountants Report to the Members of Solent Multiple Sclerosis Therapies Limited

As described on the balance sheet you are responsible for the preparation of the accounts for the year ended 31 March 2021 set out on pages 3 to 10 and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited accounts, in order to assist in the fulfilment of your statutory responsibilities, from accounting records and information and explanations supplied to us.

Huntersev essucsusesesvertisesssessivssaessessietsseessenesesSimmons Ltd

pated...'S 2] 202

EMP Building, Unit1 4 Solent Road Havant Hampshire POS 1JH

2

7

Solent Multiple Sclerosis Therapies Limited Statement of Financial Activities For the Period Ended 31 March 2021

Notes Mar-21 Mar-20
Rg £
Genera! Fund
Incoming Resources:
Donations:
Donations and Gifts 69,109 114,866
Investment Income 749 1,619
Income from trading activities:
Related to objects ofthe charity 0 0
Total incoming resources 69,858 116,485
Resources Expended:
Direct Charitable Expenditure 30,705 68,757
Fund Raising and Publicity 299 2,056
Managementand Administration 3 67,190 76,885
Total resources expended 4 98,194 147,698
Net incoming resources 5 (28,336) (31,213)
Balances at 31 March 2020 375,060 406,273
Balancesat31March2021 346,724 375,060

3

|

Solent Multiple Sclerosis Therapies Limited Income and Expenditure Account For the Period Ended 31 March 2021

----- Start of picture text -----
|||||||| |---|---|---|---|---|---|---| |Mar-21|Mar-20| |£|£| |Total|Income|from|continuing|operations|69,858|116,485| |Total|expenditure|from|continuing|operations|98,194|147,698| |Net|income/{expenditure)|for the year|(28,336)|(31,213)|

----- End of picture text -----

There are no recognised gains or losses in 2021 or 2020 other than the net income for the years.

The notes on pages 7 to 10 form part of these accounts 4

Solent Multiple Sclerosis Therapies Limited Balance Sheet As at 31 March 2021

Notes Mar-21 Mar-20
£ £ £ £
Fixed Assets
Tangible Assets 8 235,677 238,460
CurrentAssets
Stocks 9 374 374
Prepayments - 2,399
Cash atBankand in Hand 145,449 162,574
145,823 165,347
Creditors: Amounts due withIn oneyear
Other creditors 10 15,688 9,659
Net CurrentAssets 130,135 155,688
Total NetAssets 365,812 394,148
Fund Balances
Incomeand ExpenditureAccount 346,724 375,060
Reserved Capital 3,200 3,200
Operating Reserve Account 15,888 15,888
TotalFundBalances 365,812 394,148

The Balance Sheet continues on the following page . The notes on pages 7 to 10 form part of these accounts

5

Solent Multiple Sclerosis Therapies Limited Balance Sheet (continued) As at 31 March 2021

Directors’ Statement

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies, for the period ended 31 March 2021.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2021 in accordance with Section 476 of the Companies Act 2006,

The directors acknowledge their responsibilities for:

,

The accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies and with the Financial Reporting Standard for Smaller Entities (effective April 2008).

These accounts were approved on.....! aa BORN.

----- Start of picture text -----
chlbedbewse: cesvwDirector Gee Ry Woennouwsk
Paul Lee
Mee 2
----- End of picture text -----

The notes on pages 7 to 10 form part of these accounts

6

:

!

Solent Multiple Sclerosis Therapies Limited Notes to the Accounts For the Period Ended 31 March 2021

1 ACCOUNTING POLICIES

Basis of Accounting

These accounts have been prepared on the basis of the historical cost convention in accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008) and with applicable Accounting Standards, the Accounting and Reporting by Charities - Statement of Recommended Practice (SORP 2005) and the Charities Act 1993.

Incoming Resources

incoming resources are reported gross.

Legacies and Donations

Legacies and donations are accounted for when the resources are receivable or when the charity's entitlement is legally enforceable. Legacies received in the form of property and investments are credited at the lower of probate and market value. Other gifts in kind are included in the accounts at market value. Assets for distribution are recognised only when distributed; assets given for use by the charity are recognised when receivable; stocks of unsold donated goods are not valued for balance sheet purposes.

Grants Receivable

Grants are recognised when receivable.

Direct Charitable Expenditure, Fund Raising, Management and Administration Direct charitable expenditure comprises ail expenditure directly relating to the objects of the charity. When necessary, costs are allocated between direct charitable expenditure fund-raising and management and administration on the basis of apportionment of the relevant expenditure.

Life Subscriptions

There are no life subscriptions

Commitments

Commitments made by the directors that are legally binding have been accrued. Those that are not legally binding have not been charged in the accounts, but disclosed in note 11.

Tangible Flxed Assets and Depreciation

Tangible fixed assets are stated at cost.

Depreciation is provided over the expected useful lives of each category of tangible fixed asset as follows:

Furniture and Office Equipment 25% on net book value Plant and Equipment 25% on net book value Buildings Depreciated to reflect a valuation of £35000 Improvements to Freehold Property 2% on cost The Compression Chamber and previous Improvements to Freehold Property are fully depreciated.

Freehold Land has not been depreciated.

7

Solent Multiple Sclerosis Therapies Limited Notes to the Accounts For the Period Ended 31 March 2021

1 ACCOUNTING POLICIES (continued)

Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for any obsolete or slow-moving items. Cost includes direct materials, labour and overheads incurred in providing each service. Net realisable value is based on estimated selling price less selling costs.

Cash Flow Statement

The company has taken advantage of the exemption in the Financial Reporting Standard 1 from the requirement to disclose a Statement of Cash Flows on the grounds that it is a small company.

2 INVESTMENT INCOME

2 INVESTMENT INCOME
War-21 Mar-20
£ E
Bank Interest Receivable 749 1,619
3 MANAGEMENT AND ADMINISTRATION
Mar-21 Mar-20
E £
Central Managementand Administration 67,190 76,885
4 ANALYSIS OF TOTAL RESOURCES EXPENDED
Mar-21 Mar-20
E £
Salaries 67,190 76,885
Utilities 1,389 3,773
Supplies 20,688 58,879
Depreciation 8,927 8,164
98,194 147,698
5 NET INCOMING RESOURCES
Mar-21 Mar-20
£ £
This is stated aftercharging:
Depreciation 8,927 8,161

8

Solent Multiple Sclerosis Therapies Limited Notes to the Accounts For the Period Ended 31 March 2021

6 INTEREST PAYABLE LESS RECEIVABLE INTEREST PAYABLE LESS RECEIVABLE INTEREST PAYABLE LESS RECEIVABLE
Mar-21 Mar-20
£ Rg
Bank Interest Receivable 749 1619
7 TAXATION
No corporation tax is payable as thecompany company is a registered charity.
8 TANGIBLE FIXEDASSETS
Imp's to Com- Plant —-Furniture :
Freehold Freehold pression and and Office
Property Property Chamber Equipment Equipment Total
Cost
Brought Forward 254,222 39,884 22,244 60,376 6,134 382,860
Additions 6,144 6,144
Disposals
Carried Forward 254,222 39,884 22,244 66,520 6,134 389,004
Depreciation
Brought Forward 59,980 4,884 22,244 51,821 5,471 144,400
Charge forthe year 5,084 3,678 165 8,927
Eliminated on disp's
Carried Forward 65,064 4,884 22,244 55,499 5,636 153,327
Net Book Value
At 31.03.21 189,158 35,000 - 11,021 498 235,677
At31.03.20 194,242 35,000 - 8,555 663 238,460

The Improvements to Freehold Property represent the costs incurred for the major refurbishment of the Therapy Centre at Hewett Road, North End, Portsmouth.

The works were completed in 2008.

9 STOCK
. Mar-21 Mar-20
£ £
Goodsforresale 374 374

9

Solent Multiple Sclerosis Therapies Limited Notes to the Accounts For the Period Ended 31 March 2021

10 CREDITORS: AMOUNTS DUE WITHIN ONE YEAR

Mar-21 Mar-20
g £
Taxation and social security 13,236 8,633
Accruals 4,026 1,026
Other creditors 1,426 ~
15,688 9,659

11 LIMITED LIABILITY

Every member of the company undertakes to contribute to the assets of the company, in the event of the company being wound up, an amount not exceeding £1.

10

Solent Multiple Sclerosis Therapies Limited Summary Income and Expenditure Account For the Period Ended 31 March 2021

----- Start of picture text -----
||||||||| |---|---|---|---|---|---|---|---| |Mar-21|Mar-20| |£|g| |Income|69,858|116,485| |69,858|116,485| |Expenditure| |Oxygen|4,959|7,579| |Splints|0|0| |Salaries|67,190|76,885| |Building|and|Equipment|Repairs|and|Renewals|3,597|7,347| |Utilities|1,389|3,773| |General|Office|and|Running|Costs|2,999|7,672| |Insurance|Premiums|3,220|4,360| |Diet|Supplements,|Vitamins|and|Goods|for Resale|148|578| |Provision|of Physio|and|Therapists|4,278|27,575| |Fund|Raising|Expenses|299|2,056| |Professional|Fees|1,188|1,712| |HMRC|Penalty|0|0| |Depreciation|8,927|8,161| |98,194|147,698| |Net|Surplus/(Deficit)|for the Year|(28,336)|(31,213)|

----- End of picture text -----

11

Solent Multiple Sclerosis Therapies Limited Income Detail

For the Period Ended 31 March 2021

Mar-21 Mar-20
£ £
APS 50 395
Bank interest 749 1,619
Bequests
Bonus ball 679 910
Cash control difference - 127
Collections 32 4,504
Community events 623 4,068
Corporate grants 664 9,325
Direct book sales - 114
Direct debit donations 696
Ebay shop 5,427 3,363
EPO 221 542
Equipment donations - 245
Gift aid 806 1,099
HDOTdonation 14,413 46,054
Individual donations 12,031 8,980
HMRC Job Retention Scheme 23,911 -
Masons donations 250 300
Membership 2,600 3,277
Osteo donation - 348
Physio donation 3,002 17,302
Raffles & softgames - 310
Reflex donations 990 6,526
Shiatsu donations 120 2,265
Solar panel payment 1,594 160
Sponsored events - 6,324
Store/pot collections
Trust donations 1,000 1,328
Used equipment donation
Yogagroup

69,858 116,485

12

Solent Multiple Sclerosis Therapies Limited Therapy Analysis For the Period Ended 31 March 2021

Surplus/
Donations Costs (Deficit)
£ £ g
Physio 3,002 3,346 (344)
Osteo 0 0 0
Reflex 9980 782 208
Shiatsu 120 150 (30)
4,112 4,278 (166)

.

13

Solent Multiple Sclerosis Therapies Limited Bank Analysis

For the Period Ended 31 March 2021

----- Start of picture text -----
|||||||| |---|---|---|---|---|---|---| |Mar-21|Mar-20| |Lloyds|TSB| |Current|account|6,652|9,423| |CAF|Bank|accounts| |CAFCash|account|10,124|6,326| |Scottish|Widows|Bank|1,037|7,036| |Air|Receiver &|Deluge|Tank|Fund|40,572|60,276| |HDOT chamber emergency|85,226|84,809| |replacement|reserve| |Paypal|1,838|704| |Total|Bank|Balances|145,449|162,574| |Cash|in|transit|(unbanked|cash)|-|-| |Total|Bank and|Cash|145,449|162,574| |Balance|per accounts|145,449|162,574|

----- End of picture text -----

14

Solent Multiple Sclerosis Therapies Limited Detailed Income and Expenditure Account For the Period Ended 31 March 2021

Mar-21 Mar-20
£ £
Income 69,858 116,485
69,858 116,485
Direct Costs
Fund Raising Costs 299 2,056
Provision of Physio and Therapists 4,278
less contribution 0 4,278 27,575
Oxygen 4,959
less contribution 0 4,959 7,579
Splints 0 0
EPO 148 578
Payroll Costs 67,190 76,885
76,874 114,673
GrossSurplus (7,016) 1,812
Overheads
Building and Equipment Repairs and Renewals 3,597 7,347
Utilities 1,389 3,773
General Office and Running Costs 2,999 7,672
Professional Fees 1,188 1,712
HMRC Penalty 0 0
Depreciation
Insurance
8,927
3,220
8,161
4,360
21,320 33,025
NetSurplius/(Deflcit)fortheyear (28,336) (31,213)
Building and Equipment Repairs and Renewals
Repairs and Maintenance
Building
Chamber
3,207
390
3,597
6,453
894
7,347
General Office and Running Costs
StaffTraining 523 540
Miscellaneous 199 746
Telephone 820 807
Postage and Stationery 394 354
ComputerCosts 0 71
Subscriptions
Bankcharges
200
138
0
432
Cleaning and Hygiene 725 4,722
2,999 7,672

16

Solent Multiple Sclerosis Therapies Limited Fixed Assets For the Period Ended 31 March 2021

Imp’s to Com- Plant Furniture
Freehold Freehold pression and and Office
Property Property Chamber Equipment Equipment Total
Cost
BroughtForward
Additions
254,222
-
39,884
-
22,244
-
60,376
6,144
6,134
-
382,860
6,144
Disposals
Carried Forward
-
254 222
-
39,884
-
22,244
-
66,520
-
6,134
-
389,004
Depreciation
Brought Forward 59,980 4,884 22,244 51,821 5,471 144,400
Charge fortheyear 5,084 - - 3,678 165 8,927
Eliminated on disp's - - - - - -
Carried Forward 65,064 4,884 22,244 55,499 5,636 153,327
Net Book Value
At31.03.21 189,158 35,000 - 11,021 498 235,677
At31.03.20 194,242 35,000 - 8,555 663 238,460

15